Published in Arch Pathol Lab Med on April 01, 2005
Toward routine use of 3D histopathology as a research tool. Am J Pathol (2012) 1.73
Microtome-free 3-dimensional confocal imaging method for visualization of mouse intestine with subcellular-level resolution. Gastroenterology (2009) 0.94
3-dimensional digital reconstruction of the murine coronary system for the evaluation of chronic allograft vasculopathy. Diagn Pathol (2015) 0.80
Reconstruction of 3-dimensional histology volume and its application to study mouse mammary glands. J Vis Exp (2014) 0.79
3-D visualization and quantitation of microvessels in transparent human colorectal carcinoma [corrected]. PLoS One (2013) 0.78
Application of three-dimensional imaging to the intestinal crypt organoids and biopsied intestinal tissues. ScientificWorldJournal (2013) 0.77
Computer-aided three-dimensional reconstruction of main vessels in hemangiomas. Int J Clin Exp Med (2015) 0.75
Three-dimensional Imaging and Scanning: Current and Future Applications for Pathology. J Pathol Inform (2017) 0.75
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial. Gastroenterology (2007) 3.32
Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci (2010) 2.86
DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem (2007) 2.65
Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One (2008) 2.46
Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol (2006) 2.21
Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role. Helicobacter (2004) 1.59
Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples. PLoS One (2009) 1.55
Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease. Gastroenterology (2010) 1.50
[Autoimmune pancreatitis]. Orv Hetil (2008) 1.43
[Appearing of bone marrow derived stem cells in healthy and regenerating colonic epithelium]. Orv Hetil (2009) 1.40
[Treatment prospects of lysosomal storage disorders]. Orv Hetil (2008) 1.40
Does dermatitis herpetiformis result in bone loss as coeliac disease does? A cross sectional study. Rev Esp Enferm Dig (2013) 1.40
Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions. PLoS One (2010) 1.40
Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PLoS One (2012) 1.35
Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm Bowel Dis (2009) 1.35
New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Am J Gastroenterol (2007) 1.27
Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas. Gastroenterology (2006) 1.26
Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature. Dis Markers (2008) 1.24
Changes of the cytokine profile in inflammatory bowel diseases. World J Gastroenterol (2012) 1.23
New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe. J Med Genet (2013) 1.22
Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res (2006) 1.20
Highly expressed genes are associated with inverse antisense transcription in mouse. J Genet (2007) 1.19
Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. World J Gastroenterol (2005) 1.19
Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer. BMC Cancer (2008) 1.16
Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results. Cancer Epidemiol Biomarkers Prev (2008) 1.15
Antioxidant measurements. Physiol Meas (2007) 1.14
Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker. PLoS One (2010) 1.08
Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm Bowel Dis (2007) 1.05
Herpes in STAT1 gain-of-function mutation [corrected]. Lancet (2012) 1.04
Wireless capsule endoscopy in the diagnosis of helminthiasis. Gastrointest Endosc (2007) 1.02
Dysplasia-carcinoma transition specific transcripts in colonic biopsy samples. PLoS One (2012) 1.01
Genetic polymorphisms of NOD1 and IL-8, but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori-induced duodenal ulcer and gastritis. Helicobacter (2007) 1.01
Serrated pathway: alternative route to colorectal cancer. World J Gastroenterol (2013) 0.99
Update on the pharmacogenomics of proton pump inhibitors. Pharmacogenomics (2011) 0.98
[The problem of multiple testing and solutions for genome-wide studies]. Orv Hetil (2005) 0.97
Molecular detection of circulating cancer cells. Role in diagnosis, prognosis and follow-up of colon cancer patients. Dig Dis (2003) 0.97
Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island. BMC Cancer (2013) 0.97
Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel diseases: ulcerative colitis shows specific p53- and EGFR expression alterations. Dis Colon Rectum (2005) 0.97
The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer. Int J Mol Sci (2012) 0.96
Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis. World J Gastroenterol (2007) 0.96
Carcinogenesis in inflammatory bowel disease. Dig Dis (2007) 0.96
Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes. Cell Oncol (2009) 0.96
Molecular pathogenesis of Helicobacter pylori infection: the role of bacterial virulence factors. Dig Dis (2010) 0.95
Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon. Pathol Oncol Res (2008) 0.94
Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease. Mol Cancer Res (2007) 0.94
Mutant p53 expression and apoptotic activity of Helicobacter pylori positive and negative gastritis in correlation with the presence of intestinal metaplasia. Eur J Gastroenterol Hepatol (2003) 0.93
The role of the bone marrow derived mesenchymal stem cells in colonic epithelial regeneration. Pathol Oncol Res (2010) 0.93
Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy. Inflamm Bowel Dis (2007) 0.93
The behavior of matrix metalloproteinase-9 in lymphocytic colitis, collagenous colitis and ulcerative colitis. Pathol Oncol Res (2011) 0.93
Infliximab therapy improves the bone metabolism in fistulizing Crohn's disease. Dig Dis (2006) 0.93
Genome-wide screening of genes regulated by DNA methylation in colon cancer development. PLoS One (2012) 0.92
Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort. Inflamm Bowel Dis (2009) 0.92
The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer. Pathol Oncol Res (2011) 0.92
The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases. Dig Dis (2012) 0.92
Immunophenotypic profiling of nonsmall cell lung cancer progression using the tissue microarray approach. Appl Immunohistochem Mol Morphol (2007) 0.92
Effect of proton-pump inhibitor therapy on serum chromogranin a level. Digestion (2011) 0.91
Elevated insulin-like growth factor 1 receptor, hepatocyte growth factor receptor and telomerase protein expression in mild ulcerative colitis. Scand J Gastroenterol (2008) 0.91
Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects. World J Gastroenterol (2013) 0.91
Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn's disease and psoriasis. Inflamm Res (2012) 0.90
[Epidemiology, risk factors and molecular pathogenesis of primary liver cancer]. Orv Hetil (2008) 0.89
Clinical presentation of Crohn's disease. association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery. Hepatogastroenterology (2005) 0.89
Role of DNA methylation in colorectal carcinogenesis. Dig Dis (2012) 0.89
Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program. Inflamm Bowel Dis (2015) 0.89
Automated classification of inflammation in colon histological sections based on digital microscopy and advanced image analysis. Cytometry A (2008) 0.88
Complete genes may pass from food to human blood. PLoS One (2013) 0.87
Technical note on the validation of a semi-automated image analysis software application for estrogen and progesterone receptor detection in breast cancer. Diagn Pathol (2011) 0.87
NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients. World J Gastroenterol (2010) 0.87
Plasma carnitine ester profiles in Crohn's disease patients characterized for SLC22A4 C1672T and SLC22A5 G-207C genotypes. Br J Nutr (2007) 0.87
Significantly elevated Helicobacter pylori density and different genotype distribution in erosions as compared with normal gastric biopsy specimen detected by quantitative real-time PCR. Eur J Gastroenterol Hepatol (2008) 0.86
Polymorphisms of the ApoE, HSD3B1, IL-1beta and p53 genes are associated with the development of early uremic complications in diabetic patients: results of a DNA resequencing array study. Int J Mol Med (2009) 0.85
3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial. J Crohns Colitis (2010) 0.85
Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk. Dig Dis (2014) 0.85
Chemoprevention of colorectal cancer: feasibility in everyday practice? Eur J Cancer Prev (2008) 0.85
Protein microchips in biomedicine and biomarker discovery. Electrophoresis (2007) 0.85
Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer. J Cancer Res Clin Oncol (2003) 0.85
Bone mineral density and bone acquisition in children and young adults with cystic fibrosis: a follow-up study. J Pediatr Gastroenterol Nutr (2004) 0.84
Laser microdissection in translational and clinical research. Cytometry A (2006) 0.84
Peptic esophageal stricture: medical treatment. Dig Dis (2009) 0.84
[Risk factors for esophageal cancer, and possible genetic background]. Orv Hetil (2009) 0.84
Regeneration associated growth factor receptor and epithelial marker expression in lymphoid aggregates of ulcerative colitis. Scand J Gastroenterol (2010) 0.84
ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases. Scand J Gastroenterol (2007) 0.83
Digital microscopy for boosting database integration and analysis in TMA studies. Methods Mol Biol (2010) 0.83
Carcinoma arising in enterocutan fistulae of Crohn's disease patients: description of two cases. Int J Colorectal Dis (2005) 0.83
Lymphoid aggregates may contribute to the migration and epithelial commitment of bone marrow-derived cells in colonic mucosa. J Clin Pathol (2011) 0.83
Effect of ageing on colonic mucosal regeneration. World J Gastroenterol (2011) 0.83
Helicobacter pylori and antrum erosion-specific gene expression patterns: the discriminative role of CXCL13 and VCAM1 transcripts. Helicobacter (2008) 0.83
[Gaucher's disease: pathogenesis, diagnosis and therapy]. Orv Hetil (2004) 0.83
Diagnosis and recognition of early esophageal neoplasia. Dig Dis (2009) 0.83
The results of the expression array studies correlate and enhance the known genetic basis of gastric and colorectal cancer. Cytometry B Clin Cytom (2005) 0.82